Schonfeld Strategic Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-39,783	Closed	-$127K	–	1992
2025 Q1	$127K	Sell	39,783 -89,293	-69%	-$284K	﹤0.01%	1869
2024 Q4	$691K	Sell	129,076 -202,284	-61%	-$1.08M	﹤0.01%	1217
2024 Q3	$1.75M	Buy	+331,360	New	+$1.75M	0.01%	815